<- Back to digest

JBJS - 2026-10-05 - Journal Article

Biologic and Synthetic Augmentation in Rotator Cuff Repair: Emerging Technologies.

Boufadel P, Daher M, Satalich JR, Su F, Lindsay A, Khan AZ, Black EM, Abboud JA, Kassam HF

systematic reviewLOE Vn = N/AN/A

Topics

shoulder elbowsports
PMID: 42832585DOI: 10.2106/JBJS.26.00106View on PubMed ->

Key Takeaway

Bioinductive collagen implants have the highest level of evidence (Level I) for rotator cuff augmentation, demonstrating improved structural healing and reduced retear rates, while xenograft augmentation is no longer supported.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This narrative review evaluates biologic and synthetic augmentation strategies for rotator cuff repair across xenograft, allograft, synthetic scaffold, bioinductive collagen implant, and biceps tendon autograft categories. Bioinductive collagen implants are supported by Level-I evidence showing improved structural healing and reduced retear rates in selected patients. Xenograft is condemned due to inflammatory responses and inconsistent outcomes; allograft and synthetic grafts lack sufficient evidence to define optimal indications.

Key Limitation

As a narrative rather than systematic review, no quantitative synthesis of retear rates or functional outcomes across augmentation types is provided, limiting direct head-to-head comparison.

Original Abstract

➢ Biologic and synthetic augmentation grafts have been developed to enhance both the mechanical integrity of rotator cuff repairs and the biologic healing at the tendon-bone interface, particularly in the setting of compromised tissue quality.➢ Xenograft augmentation is no longer favored because of inconsistent clinical outcomes, inflammatory responses, and a lack of supportive high-quality evidence.➢ Allograft and synthetic graft augmentation may provide benefit in selected cases; however, optimal indications, implant selection, and long-term outcomes remain incompletely defined.➢ Bioinductive collagen implants currently demonstrate the highest level of clinical evidence, with Level-I studies supporting improved structural healing and reduced retear rates in appropriately selected patients.➢ The long head of the biceps tendon autograft represents a viable, cost-effective biologic augmentation option when available, providing favorable biologic compatibility and surgical versatility.